Clinical significance of D-dimer levels during acute period in ischemic stroke

[1]  Yongseok Lee,et al.  High triglyceride-glucose index is associated with early recurrent ischemic lesion in acute ischemic stroke , 2021, Scientific Reports.

[2]  P. Myint,et al.  Prognosis of Acute Ischaemic Stroke Patients with Cancer: A National Inpatient Sample Study , 2021, Cancers.

[3]  T. Münzel,et al.  Impact of pulmonary embolism on in-hospital mortality of patients with ischemic stroke , 2020, Journal of the Neurological Sciences.

[4]  P. Gorelick,et al.  Neurologic deterioration in patients with acute ischemic stroke or transient ischemic attack , 2020, Neurology.

[5]  Hongwei Sun,et al.  Combined prognostic significance of D-dimer level and platelet count in acute ischemic stroke. , 2020, Thrombosis research.

[6]  M. Koga,et al.  D-dimer level and outcome of minor ischemic stroke with large vessel occlusion , 2020, Journal of the Neurological Sciences.

[7]  M. Ahn,et al.  Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms , 2020, Journal of stroke.

[8]  A. Demchuk,et al.  The emerging value of serum D-dimer measurement in the work-up and management of ischemic stroke , 2020, International journal of stroke : official journal of the International Stroke Society.

[9]  F. D’Aragon,et al.  Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability. , 2019, The New England journal of medicine.

[10]  M. Gou,et al.  Prognostic role of early D-dimer level in patients with acute ischemic stroke , 2019, PloS one.

[11]  G. Lippi,et al.  D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications , 2018, Critical reviews in clinical laboratory sciences.

[12]  A. Demchuk,et al.  Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke , 2017, PloS one.

[13]  T. J. Kim,et al.  D‐dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer , 2017, European journal of neurology.

[14]  G. Dangas,et al.  The current role and future prospects of D-dimer biomarker. , 2016, European heart journal. Cardiovascular pharmacotherapy.

[15]  E. Ota,et al.  Diagnostic test accuracy of D-dimer for acute aortic syndrome: systematic review and meta-analysis of 22 studies with 5000 subjects , 2016, Scientific Reports.

[16]  Sung-Chun Tang,et al.  High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis , 2016, Cerebrovascular Diseases.

[17]  J. Marler,et al.  National Institutes of Health Stroke Scale , 2016 .

[18]  A. Xu,et al.  The Role of Hs-CRP, D-Dimer and Fibrinogen in Differentiating Etiological Subtypes of Ischemic Stroke , 2015, PloS one.

[19]  J. Baron,et al.  Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  Shane Gao,et al.  Plasma D-Dimer Predicts Short-Term Poor Outcome after Acute Ischemic Stroke , 2014, PloS one.

[21]  Jie Shuai,et al.  Plasma D-Dimer Levels Are Associated with Stroke Subtypes and Infarction Volume in Patients with Acute Ischemic Stroke , 2014, PloS one.

[22]  Kortaro Tanaka,et al.  Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype. , 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[23]  S. Martin-Schild,et al.  Early Neurological Deterioration (END) after Stroke: The END Depends on the Definition , 2011, International journal of stroke : official journal of the International Stroke Society.

[24]  C. Chung,et al.  Ischemic Stroke and Cancer: Stroke Severely Impacts Cancer Patients, While Cancer Increases the Number of Strokes , 2011, Journal of clinical neurology.

[25]  S. Kwon,et al.  Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke. , 2009, Stroke.

[26]  S. Kasner,et al.  Clinical Usefulness of a Biomarker-Based Diagnostic Test for Acute Stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) Study , 2009, Stroke.

[27]  C. Molina,et al.  Etiologic Diagnosis of Ischemic Stroke Subtypes With Plasma Biomarkers , 2008, Stroke.

[28]  M. Bissell.  d-Dimer Predicts Early Clinical Progression in Ischemic Stroke: Confirmation Using Routine Clinical AssaysBarber M, Langhorne P, Rumley A, et al (Royal Infirmary, Glasgow, England) Stroke 37: 1113–1115, 2006 , 2008 .

[29]  P. Langhorne,et al.  d-Dimer Predicts Early Clinical Progression in Ischemic Stroke: Confirmation Using Routine Clinical Assays , 2006, Stroke.

[30]  P. Langhorne,et al.  Confirmation Using Routine Clinical Assays , 2006 .

[31]  U. Bogdahn,et al.  The relationship between plasma D-dimer concentrations and acute ischemic stroke subtypes. , 2005, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[32]  P. Langhorne,et al.  Hemostatic Function and Progressing Ischemic Stroke: D-dimer Predicts Early Clinical Progression , 2004, Stroke.

[33]  D. Propp,et al.  D-dimer in venous thromboembolism. , 2004, The New England journal of medicine.

[34]  Jonathan Dreyer,et al.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. , 2003, The New England journal of medicine.

[35]  W. Ageno,et al.  Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. , 2002, Archives of internal medicine.

[36]  M. Dennis,et al.  Venous thromboembolism after acute stroke. , 2001, Stroke.

[37]  J. Danesh,et al.  Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.

[38]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.